Operating in China means navigating one of the world’s most complex anti-corruption environments. Between China’s own domestic laws targeting commercial bribery, the U.S. Foreign Corrupt Practices Act (FCPA), and the UK Bribery Act, foreign companies doing business in China face a multi-jurisdictional compliance challenge that has resulted in nine-figure fines, executive imprisonment, and irreparable reputational damage. This guide breaks down the specific laws you must understand, the grey zones where most violations occur, and how to build an anti-bribery compliance program suited to the China market.
The Legal Landscape: Three Laws Every Foreign Company Must Know
Foreign companies operating in China are simultaneously subject to Chinese domestic law and the extraterritorial reach of Western anti-corruption legislation. Understanding where these regimes overlap is the foundation of any sensible compliance posture.
China’s Anti-Unfair Competition Law (AUCL)
China’s primary commercial bribery statute is the Ministry of Commerce-enforced Anti-Unfair Competition Law (AUCL), originally enacted in 1993 and substantially revised in 2017 and again in 2022. Article 7 prohibits business operators from bribing counterparties or third parties to obtain transaction opportunities or competitive advantages, covering payments to employees of the counterparty, to units or individuals influencing the transaction, and the use of off-the-books funds. Penalties range from RMB 100,000 to RMB 3 million in administrative fines, with criminal referrals under Articles 163 and 164 of China’s Criminal Law carrying up to 10 years imprisonment. The State Administration for Market Regulation (SAMR) is the primary enforcement body.
The Foreign Corrupt Practices Act (FCPA)
The U.S. Department of Justice enforces the FCPA against U.S. companies, U.S. persons, and any foreign company listed on a U.S. stock exchange. The FCPA prohibits corrupt payments to “foreign officials” in exchange for obtaining or retaining business. In the China context, this is particularly treacherous because employees of state-owned enterprises (SOEs) are routinely classified as “foreign officials” under the FCPA even when their day-to-day role appears entirely commercial. China has historically generated more FCPA enforcement actions than any other single country. Major enforcement cases have involved pharmaceutical companies, medical device manufacturers, and construction firms paying kickbacks to hospital administrators and government procurement officers. Penalties routinely exceed $100 million, with some pharmaceutical cases reaching over $500 million in combined DOJ and SEC settlements.
The UK Bribery Act
British companies and any company with a UK nexus face additional exposure under the UK Bribery Act 2010, which is broader than the FCPA in one critical respect: it covers private-to-private bribery with no carve-out for facilitating payments. Companies with UK operations conducting business in China must maintain documented “adequate procedures” to avoid strict corporate liability.
Where Foreign Companies Most Often Go Wrong in China
Most FCPA and AUCL violations in China do not originate in the boardroom. They arise in the field, often facilitated by third parties acting on the company’s behalf without direct executive knowledge.
Third-Party Distributors and Agents
Perhaps the single greatest compliance risk in China is the domestic distributor or sales agent. Foreign companies frequently rely on local intermediaries who have existing government and SOE relationships, and these intermediaries may channel funds in ways that create FCPA or AUCL liability for the principal. The standard FCPA predecessor doctrine holds that what the agent does on your behalf is attributed to the principal. Due diligence on distributors cannot be an afterthought. If you have not already read our guide on how to conduct proper due diligence on a Chinese supplier, that process applies equally to channel partners.
Entertainment, Gifts, and Travel
Chinese business culture places significant weight on relationship-building through hospitality. Banquets, gifts during festivals, and sponsored travel are all normalized in domestic Chinese business. The compliance problem arises when the recipient is a government official or SOE employee. Both the FCPA and the AUCL explicitly cover gifts and entertainment as forms of bribery when given with corrupt intent. Most multinationals cap per-occasion gifts at RMB 200 to 300 and require managerial approval for entertainment exceeding RMB 500 per person.
Government Procurement and Tender Processes
Foreign companies competing for public tenders must be disciplined about what information they seek, who they communicate with during tender evaluation periods, and how they engage consultants who claim to have insider access. For a deeper look at the tender process itself, see our guide on how to win a Chinese government tender.
Healthcare and Pharmaceutical Sectors
China’s healthcare sector remains a persistent FCPA hotspot. Hospital formulary inclusion, drug approvals, medical device procurement, and clinical trial approvals all involve interactions with government-affiliated institutions. Following a wave of pharmaceutical enforcement actions between 2013 and 2016, most major multinational pharma companies restructured their China sales models, moving away from commission-based representatives toward salaried, compliance-certified teams. The National Health Commission (NHC) regularly issues updated guidance on commercial interactions with healthcare professionals.
China’s Anti-Corruption Campaign: What It Means for Business
Since 2012, China’s Central Commission for Discipline Inspection (CCDI) has conducted the most sustained anti-corruption campaign in the country’s modern history, with more than 4 million officials investigated or disciplined. This has had a paradoxical effect on foreign companies: petty bribery demands from lower-level officials have declined, but officials who previously accepted hospitality are now more likely to report foreign company conduct retroactively to insulate themselves from scrutiny. The practical implication is that behaviors that went unnoticed in 2010 may now generate enforcement referrals. Foreign companies should audit their historical practices in China, not just their current ones.
Building a China-Specific Anti-Bribery Compliance Program
Generic global compliance programs frequently fail in China because they are not calibrated to local risk. An effective China-specific program requires the following components.
Risk Assessment by Business Line
A B2B software business selling to private enterprise carries fundamentally different risk from a medical device company selling to public hospitals. Map your actual touchpoints with government officials and SOE employees, and segment your distributors by the nature of their government relationships. This segmentation should drive proportionate due diligence and monitoring requirements.
Third-Party Due Diligence That Reflects China’s SOE Landscape
Approximately 150,000 state-owned enterprises operate at central and local government levels in China. An entity may appear to be a private company while being majority-owned by a local government investment vehicle. Due diligence must include beneficial ownership analysis, state ownership screening, and an assessment of whether key decision-makers hold Communist Party positions. Our post on China’s Anti-Monopoly Law also addresses how SOE structures affect regulatory interactions.
Training in Mandarin, Scenario-Based
Anti-bribery training conducted exclusively in English will not reach the people most likely to face bribery situations: your local sales team, your distributor’s account managers, and your procurement staff. Mandate Mandarin-language training with scenario-based examples drawn from your specific industry. Document completion and retention rates. This documentation matters enormously if you face a DOJ or SAMR investigation, because it evidences a good-faith compliance culture.
Speak-Up Channels That Work in a Chinese Cultural Context
Hotlines frequently fail in China because cultural norms of group harmony and deference to hierarchy make employees reluctant to report concerns about colleagues or supervisors. An effective speak-up program must be genuinely anonymous, Mandarin-accessible, managed by a third-party provider with no visible connection to China management, and backed by a demonstrated non-retaliation policy.
Key Takeaways for Executives
China’s anti-bribery environment is more sophisticated and more actively enforced than it was a decade ago, from both Chinese and American regulatory sides. The DOJ’s FCPA Resource Guide remains the essential reference for understanding enforcement criteria. For navigating partner misconduct issues that surface during a compliance review, our guide on handling Chinese partner disputes without going to court covers relevant options. The companies that manage this risk successfully are those with compliance cultures embedded at the sales management level, with third-party programs that genuinely scrutinize SOE ownership, and with training programs built for the people on the ground in China rather than for the lawyers at headquarters.